Senen Biotech
Levosulpiride (75mg) + Esomeprazole (40mg)
Somesen L 75mg/40mg Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux) by relieving symptoms such as heartburn, stomach pain, or irritation.
Capsule SR
Somesen L 75mg/40mg Capsule SR is a prescription medicine used in the treatment of gastroesophageal reflux disease (acid reflux). It works by relieving the symptoms such as heartburn, stomach pain, or irritation. It also neutralizes the acid production in the stomach to prevent discomfort.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Somesen L 75mg/40mg Capsule SR is to be taken empty stomach.
Somesen L 75mg/40mg Capsule SR is a combination of two medicines: Levosulpiride and Esomeprazole.
Do not consume alcohol while taking Somesen L 75mg/40mg Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Somesen L 75mg/40mg Capsule SR for longer than prescribed.
To store this medication safely, keep it in its original container, tightly closed. Store it according to the instructions on the pack or label. For unused medicine, dispose of it properly, ensuring it is not accessible to children, pets, or other individuals.
Take Somesen L 75mg/40mg Capsule SR exactly as directed by your healthcare provider. For optimal results, it is recommended to take one capsule daily on an empty stomach.
The use of Somesen L 75mg/40mg Capsule SR should be avoided in patients who have a known allergy to any component or excipient of this medication.
Yes, Somesen L 75mg/40mg Capsule SR may cause dizziness (feeling faint, weak, unsteady, or lightheaded) in some patients. If you experience dizziness, it is advisable to rest for a while and resume once you feel better.
Several studies suggest that treatment with Somesen L 75mg/40mg Capsule SR may be associated with an increased risk for osteoporosis-related fractures, specifically of the hip, wrist, or spine. This risk is higher in patients receiving high doses (multiple daily doses) and long-term therapy (a year or longer).